Kevin Heyries, PhDCo-Founder & Head of Business Development at AbCellera
Profile
Kevin Heyries, Ph.D. is the co-founder of Vancouver-based AbCellera and has led the development of AbCellera's antibody discovery platform that combines proprietary immunizations, microfluidics, high-throughput imaging, genomics, deep computation, artificial intelligence, and automation. Dr. Heyries has led antibody discovery programs and now leads the company’s business development and strategy activities.
Agenda Sessions
From Patient Sample to Antibody Lead in Three Weeks: A Real-Time Response to COVID-19
On DemandView SessionFrom Patient Sample to Antibody Lead in Three weeks: A Real-Time Response to COVID-19
3:15pmView Session